Stan Polovets

Stan Polovets
Станислав Половец[1]
Stan Polovets
Polovets awards Justice Ruth Bader Ginsburg the Genesis Lifetime Achievement Award in 2018
Born (1963-06-08) June 8, 1963 (age 61)
Moscow, Soviet Union
(present-day Russia)
NationalityAmerican
Occupation(s)Businessman and philanthropist
OrganizationsL1 Energy/Alfa Group, Genesis Prize Foundation, Access Industries, Edelman, Stanford University, New York University

Stan Polovets (born June 8, 1963) is an American businessman and philanthropist. He is known for his work in the international energy sector and for his innovative philanthropic initiatives.[2]

Polovets played a notable role in the creation of TNK-BP, one of the largest joint ventures in the global energy industry, which operated in 2003-2013 and controlled more than 18% of Russia’s total oil production. He held a number of executive and board posts and was instrumental in its subsequent divestment in a record $55 billion transaction.[3]

In May 2020, Polovets was elected chairman of the board of directors of Anchiano Therapeutics Ltd.,[4][5] a NASDAQ-listed biopharmaceutical company. In March 2021, he stepped down as chairman after the company posted a 630% return in 12 months, and merged with Israel-based Chemomab Therapeutics.[6]

Polovets is a member of the Council on Foreign Relations, the President’s Global Council at New York University (NYU), and the Board of Overseers at the NYU Tandon School of Engineering.[7] From 2014 to 2019, he served on the Board of Overseers of Stanford University's Hoover Institution.[8][9]

He is the co-founder and chairman/CEO of the Genesis Prize Foundation, a global philanthropic initiative focused on enhancing Jewish identity.[10][11]

  1. ^ "Представители ТНК-ВР покинули совет директоров "Славнефти"". Gazeta.ru. 25 February 2013. Archived from the original on 4 March 2016. Retrieved 21 April 2015.
  2. ^ "Stanislav Polovets: Executive Profile & Biography". Businessweek. Archived from the original on November 10, 2014.
  3. ^ "Rosneft Completes Acquisition of TNK-BP". New York Times. March 21, 2013. Archived from the original on July 9, 2015. Retrieved March 14, 2015.
  4. ^ "Anchiano Appoints Chairman Of The Board". Reuters. 2020-05-26. Archived from the original on 2021-02-13. Retrieved 2021-02-07.
  5. ^ "Stan Polovets, Genesis Prize Foundation: Profile and Biography". Bloomberg.com. Archived from the original on 2021-12-09. Retrieved 2021-02-07.
  6. ^ "Genesis Prize Co-Founder Stan Polovets Steps Down as Chairman of Anchiano Therapeutics after Company Posts 630% Return in 12 Months". edition.cnn.com. Archived from the original on 2021-04-21. Retrieved 2021-04-21.
  7. ^ "Stan Polovets Joins the Board of Overseers at Stanford University's Hoover Institution". Hoover Institution. Archived from the original on 2021-12-05. Retrieved 2021-02-07.
  8. ^ "Stan Polovets Joins the Board of Overseers at Stanford University's Hoover Institution". BusinessWire. 11 November 2014. Archived from the original on 14 November 2014. Retrieved 17 November 2014.
  9. ^ "Stan Polovets Joins the Board of Overseers at Stanford University's Hoover Institution". Hoover Institution. Archived from the original on 2014-11-27. Retrieved 2014-11-17.
  10. ^ "Russians Join Israel to Start Jewish Prize of $1 Million". New York Times. June 26, 2012. Archived from the original on November 11, 2020. Retrieved March 14, 2015.
  11. ^ "Jewish foundation creates 'Jewish Nobel Prize'". The Jerusalem Post. Archived from the original on 2014-11-11. Retrieved 2014-11-10.